Gongylonema neoplasticum

Last updated

Gongylonema neoplasticum
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Eukaryota
Kingdom: Animalia
Phylum: Nematoda
Class: Chromadorea
Order: Rhabditida
Family: Gongylonematidae
Genus: Gongylonema
Species:
G. neoplasticum
Binomial name
Gongylonema neoplasticum
(Fibiger & Ditlevsen, 1914) Ditlevsen, 1918

Gongylonema neoplasticum (more famously as Spiroptera carcinoma) is a roundworm parasite of rats. [1] It was discovered by a Danish physician Johannes Fibiger in 1907. Fibiger and Hjalmar Ditlevsen made a formal description in 1914 as Spiroptera (Gongylonema) neoplastica. But Ditlevsen gave the final valid name Gongylonema neoplasticum in 1918. The nematode is transmitted between rats and cockroaches.

Contents

When Fibiger discovered the nematode in the stomach of rats, he found that the stomach had tumours. Inspired by the possible link of the nematode and tumour, he performed experiments to induce tumours with nematode infection. He published his experimental success in 1913. The nematode experiment earned Fibiger the 1926 Nobel Prize in Physiology or Medicine, but under controversial circumstances. Moreover, it was later proven that Fibiger came to a wrong conclusion, that the nematode is not carcinogenic. Erling Norrby, who had served as the Permanent Secretary of the Royal Swedish Academy of Sciences and Professor and Chairman of Virology at the Karolinska Institute, declared Fibiger's Nobel Prize as "one of the biggest blunders made by the Karolinska Institute." [2]

Discovery

A Danish physician, Johannes Fibiger, while working as Director of the Institute of Pathological Anatomy at the University of Copenhagen, dissected some wild rats collected from Dorpat (now, Tartu, in Estonia) in 1907. He discovered nematodes and their eggs in the stomach of rats, and more importantly, the rats had stomach tumour (papilloma). He found that some tumours were metastatic (cancerous), from which he built a hypothesis that the nematodes caused stomach cancer. After five years he experimentally demonstrated that the nematode could induce stomach cancer. He published his discovery in a series of three papers in 1913, and also presented them at the Académie Royale des Sciences et des Lettres de Danemark (Royal Danish Academy of Sciences and Letters), and Troisième Conférence Internationale pour l’Étude du Cancer (Third International Conference for Researches in Cancer) at Brussels the same year. [3] [4] He knew that the nematode was a new species, and provisionally named it Spiroptera carcinom in 1914. With the help of Hjalmar Ditlevsen, of the Zoological Museum of the University of Copenhagen, he made a complete zoological description and named it Spiroptera (Gongylonema) neoplastica in 1914. [5] Ditlevsen revised the description in 1918, and gave the final valid name Gongylonema neoplasticum. [6]

Biology

Structure

G. neoplasticum is a gastrointestinal parasite of rats, Rattus norvegicus and R. rattus . The adult roundworms are present in the epithelium of the anterior portion of the digestive tract, including the mouth, tongue, oesophagus and fundus. The body is cylindrical and elongated with both ends narrowing down. The body covering called cuticle is regularly striated. Although they are structurally similar, male and female can be easily differentiated. An adult male is relatively smaller, measuring 1.5 cm long and 0.1-0.16 mm wide. Its posterior end is more pointed and bent inward. The tail end contains cloaca and precloacal sucker on the ventral side, which are surrounded by sensory structures called caudal papillae. Two thread-like projections spicules originate from the cloaca. The female is considerable larger, about 4–5 cm long and 0.23 mm to 0.33 mm in diameter. The tail is bluntly rounded. There is a single anus, but sucker and papillae are absent. [7] [8]

Life cycle

G. neoplasticum completes its life cycle in two hosts, rats as definitive hosts, and cockroaches ( Periplaneta ) as intermediate hosts. It is hermaphrodite, and has both male and female reproductive organs in the same body. The male reproductive system consists of a single testis, vas deferens, seminal vesicles, ejaculatory duct, two spicules, gubernaculum and bursa. Female reproductive organs include a pair of ovaries, oviducts, seminal receptacle, uteri and a long oviduct, vagina and vulva. The eggs are oval shaped, and enclosed in double egg membrane. They are about 57x33 μm in diameter. Inside the membrane is an embryo. Eggs are laid in the intestine of the host and excreted along with the faeces. The infested faeces are eaten by cockroaches. Inside the cockroach, the embryonic membrane is removed liberating the embryo. The embryo move to the muscle layer where it grow into a thread-like larva after 4–5 weeks. Then after 3 weeks they undergo structural modification called moulting. After this, they become infective to rats, whenever they eat an infected cockroach. [4] [9]

Nobel Prize

Fibiger's experiment was the first to show that nematodes cause cancer, and that cancer (tumour) can be experimentally induced. His discovery was supported by the experiment of two Japanese scientists Katsusaburo Yamagiwa and Koichi Ichikawa in 1918. Yamagiwa and Ichikawa showed that it was possible to induce cancer (carcinoma) in rabbits, and that the simplest method was by painting coal-tar on the inner surface of the ear. They even showed that different mechanical or chemical irritation, especially the painting of coal-tar upon the inner surface of the ear was the most effective in inducing carcinoma in rabbits. [10] A number of independent experiments subsequently confirmed the cancer-inducing effect of coal-tar in mice. [11] The importance of Fibiger's work was regarded as conclusive. He was awarded the Nobel Prize in Physiology or Medicine in 1926. [4] [12]

Controversy

From 1920 onward, Fibiger was nominated for the Nobel Prize for Physiology or Medicine 18 times. [13] In 1920, he received two nominations, and the nominations included Katsusaburo Yamagiwa. But the two assessors appointed by the Nobel Committee, Folke Henschen and Hilding Bergstrand could not come to a mutual agreement. Henschen was in favour of the prize for the two nominees, while Bergstrand was adamant that they did not deserve. Bergstand conclusion was that there was not "much support for the possibility that the work of Fibiger and Yamagiwa will have great importance in the solving of the riddle of cancer. Under such circumstances I do not consider these discoveries worthy of the Nobel Prize." [14] [15] The Nobel Committee decided not to give the 1926 award. But Fibiger, without Yamagiwa, was again considered for the award in 1927. There were two other nominees: Otto Heinrich Warburg, for his works of cancer metabolism and respiratory enzymes, and Julius Wagner-Jauregg, for the discovery of malariotherapy. The Nobel Committee resolved that Fibiger and Warburg would jointly receive the Nobel Prize for 1926, and Wagner-Jauregg for 1927. But the Karolinska Institute overruled the decision and rejected Warburg. (Warburg was eventually awarded in 1931.) Fibiger became the sole winner of the 1926 Nobel Prize in Physiology or Medicine, [4] [15] "for his discovery of the Spiroptera carcinoma". [16]

Disproof of Fibiger's discovery

Experimental evidence later refuted Fibiger's Nobel Prize discovery. In 1918, there was a critical comment from F. D. Bullock and G. L. Rohdenburg that Fibiger could have confused cancer-like (neoplastic) tumour from true (metastatic) cancer, and that he had not induced actual cancer. [17] But Fibiger responded "That these tumors are true carcinomata cannot, thus, be doubted, and the fact that they may occur in younger animals does not diminish our right to range them among the true malignant neoplasms." [3] After his death in 1928, there was a better understanding of the nature of cancer—on the differences of neoplastic tumour and malignant tumours (cancer), challenging the claims of Fibiger. The most important criticism was by Richard Douglas Passey, with his colleagues A. Léese, and J.C. Knox. Their experimental conclusions were that the nematode could not cause cancer, and that experimentally-induced cancer was due to other factors such as vitamin A deficiency. [18] Fibiger used a vitamin A-less diet for his experimental rats, and it was by then established that vitamin A deprivation alone could induce cancer. [19] [20] [21] An elaborate experiment by W. Cramer in 1937 came to the conclusion that Fibiger's tumour could not be a true cancer. [22] A more rigorous study was done by Claude R. Hitchcock and E. T. Bell in 1952. They repeated Fibiger's experiments using advanced techniques, and concluded that the tumours induced by the nematode in rats were metaplasia, not cancer. All tumours were due to vitamin A deficiency. [23] Systematic reanalysis of Fibiger's data also gave the same conclusion that G. neoplasticum can cause tumour, but is not carcinogenic by itself. [24] [25]

Related Research Articles

<span class="mw-page-title-main">Butylated hydroxyanisole</span> Chemical compound

Butylated hydroxyanisole (BHA) is a synthetic, waxy, solid petrochemical. Its antioxidant properties have caused it to be widely used as a preservative in food, food packaging, animal feed, cosmetics, pharmaceuticals, rubber, and petroleum products. BHA has been used in food since around 1947.

<span class="mw-page-title-main">Malignancy</span> Tendency of a medical condition to become progressively worse

Malignancy is the tendency of a medical condition to become progressively worse; the term is most familiar as a characterization of cancer.

Spontaneous remission, also called spontaneous healing or spontaneous regression, is an unexpected improvement or cure from a disease that usually progresses. These terms are commonly used for unexpected transient or final improvements in cancer. Spontaneous remissions concern cancers of the haematopoietic system, while spontaneous regressions concern palpable tumors; however, both terms are often used interchangeably.

<span class="mw-page-title-main">Johannes Fibiger</span> Danish physician (1867–1928)

Johannes Andreas Grib Fibiger was a Danish physician and professor of anatomical pathology at the University of Copenhagen. He was the recipient of the 1926 Nobel Prize in Physiology or Medicine "for his discovery of the Spiroptera carcinoma". He demonstrated that the roundworm which he called Spiroptera carcinoma could cause stomach cancer in rats and mice. His experimental results were later proven to be a case of mistaken conclusion. Erling Norrby, who had served as the Permanent Secretary of the Royal Swedish Academy of Sciences and Professor and Chairman of Virology at the Karolinska Institute, declared Fibiger's Nobel Prize as "one of the biggest blunders made by the Karolinska Institute."

Benzo(<i>a</i>)pyrene Carcinogenic compound found in smoke and soot

Benzo[a]pyrene (BaP or B[a]P) is a polycyclic aromatic hydrocarbon and the result of incomplete combustion of organic matter at temperatures between 300 °C (572 °F) and 600 °C (1,112 °F). The ubiquitous compound can be found in coal tar, tobacco smoke and many foods, especially grilled meats. The substance with the formula C20H12 is one of the benzopyrenes, formed by a benzene ring fused to pyrene. Its diol epoxide metabolites, more commonly known as BPDE, react with and bind to DNA, resulting in mutations and eventually cancer. It is listed as a Group 1 carcinogen by the IARC. In the 18th century a scrotal cancer of chimney sweepers, the chimney sweeps' carcinoma, was already known to be connected to soot.

Malignant transformation is the process by which cells acquire the properties of cancer. This may occur as a primary process in normal tissue, or secondarily as malignant degeneration of a previously existing benign tumor.

Since the first award in 1901, conferment of the Nobel Prize has engendered criticism and controversy. After his death in 1896, the will of Swedish industrialist Alfred Nobel established that an annual prize be awarded for service to humanity in the fields of physics, chemistry, physiology or medicine, literature, and peace. Similarly, the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel is awarded along with the Nobel Prizes.

<span class="mw-page-title-main">Carcinoembryonic antigen</span> Glycoprotein secreted into the luminal surface of the epithelia in the gastrointestinal tract

Carcinoembryonic antigen (CEA) describes a set of highly-related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Consequently, CEA is usually present at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. Serum levels can also be elevated in heavy smokers.

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses. Oncolytic viruses also have the ability to affect the tumor micro-environment in multiple ways.

<span class="mw-page-title-main">Precancerous condition</span> Condition or cell change indicating increased cancer risk

A precancerous condition is a condition, tumor or lesion involving abnormal cells which are associated with an increased risk of developing into cancer. Clinically, precancerous conditions encompass a variety of abnormal tissues with an increased risk of developing into cancer. Some of the most common precancerous conditions include certain colon polyps, which can progress into colon cancer, monoclonal gammopathy of undetermined significance, which can progress into multiple myeloma or myelodysplastic syndrome. and cervical dysplasia, which can progress into cervical cancer. Bronchial premalignant lesions can progress to squamous cell carcinoma of the lung.

<span class="mw-page-title-main">Francis Peyton Rous</span> American scientist (1879–1970)

Francis Peyton Rous was an American pathologist at the Rockefeller University known for his works in oncoviruses, blood transfusion and physiology of digestion. A medical graduate from the Johns Hopkins University, he was discouraged from becoming a practicing physician due to severe tuberculosis. After three years of working as an instructor of pathology at the University of Michigan, he became dedicated researcher at the Rockefeller Institute for Medical Research for the rest of his career.

<i>Gongylonema</i> Genus of roundworms

Gongylonema is a genus of thread-like nematode that was described by Molin in 1857. It is the only currently valid genus in the family Gongylonematidae, though the mysterious Spiruroides – usually placed in the Subuluridae, which are not closely related to Gongylonema among the Spiruria – might actually belong here. They are parasites of birds and mammals, transmitted by insects. Some 38 species are known, about 12 of which have been recorded in Europe.

miR-218 microRNA precursor family Non-coding RNA

miR-218 microRNA precursor is a small non-coding RNA that regulates gene expression by antisense binding.

Alopecia neoplastica may present as a scarring alopecia, appearing anywhere on the scalp, and it has been described with cutaneous metastasis from breast, gastric, lung, renal and pancreatic carcinomas.

mir-31

miR-31 has been characterised as a tumour suppressor miRNA, with its levels varying in breast cancer cells according to the metastatic state of the tumour. From its typical abundance in healthy tissue is a moderate decrease in non-metastatic breast cancer cell lines, and levels are almost completely absent in mouse and human metastatic breast cancer cell lines. Mir-31-5p has also been observed upregulated in Zinc Deficient rats compared to normal in ESCC and in other types of cancers when using this animal model. There has also been observed a strong encapsulation of tumour cells expressing miR-31, as well as a reduced cell survival rate. miR-31's antimetastatic effects therefore make it a potential therapeutic target for breast cancer. However, these two papers were formally retracted by the authors in 2015.

<span class="mw-page-title-main">Yamagiwa Katsusaburō</span> Japanese medical scientist (1863–1930)

Yamagiwa Katsusaburō was a Japanese pathologist who carried out pioneering work into the causes of cancer, and was the first to demonstrate chemical carcinogenesis. He was a 7-time Nobel Prize nominee.

Tumor-associated macrophages (TAMs) are a class of immune cells present in high numbers in the microenvironment of solid tumors. They are heavily involved in cancer-related inflammation. Macrophages are known to originate from bone marrow-derived blood monocytes or yolk sac progenitors, but the exact origin of TAMs in human tumors remains to be elucidated. The composition of monocyte-derived macrophages and tissue-resident macrophages in the tumor microenvironment depends on the tumor type, stage, size, and location, thus it has been proposed that TAM identity and heterogeneity is the outcome of interactions between tumor-derived, tissue-specific, and developmental signals.

<span class="mw-page-title-main">Louis Westenra Sambon</span> Italian-English physician

Louis Westenra Sambon was an Italian-English physician who played important roles in understanding the causes (etiology) of diseases. He described many pathogenic protozoans, insects, and helminths including the name Schistosoma mansoni for a blood fluke. He was an authority on the classification of parasitic tongue worms called Pentastomida (Linguatulida), and one of the genus Sambonia is named after him.

Carcinogenic parasites are parasitic organisms that depend on other organisms for their survival, and cause cancer in such hosts. Three species of flukes (trematodes) are medically-proven carcinogenic parasites, namely the urinary blood fluke, the Southeast Asian liver fluke and the Chinese liver fluke. S. haematobium is prevalent in Africa and the Middle East, and is the leading cause of bladder cancer. O. viverrini and C. sinensis are both found in eastern and southeastern Asia, and are responsible for cholangiocarcinoma. The International Agency for Research on Cancer declared them in 2009 as a Group 1 biological carcinogens in humans.

References

  1. ↑ Paramasvaran S, Sani RA, Hassan L, et al. (April 2009). "Endo-parasite fauna of rodents caught in five wet markets in Kuala Lumpur and its potential zoonotic implications" (PDF). Trop Biomed. 26 (1): 67–72. PMID   19696729.
  2. ↑ Norrby, Erling (2010). Nobel Prizes and Life Sciences. Singapore: World Scientific Publishing Co. p. 115. ISBN   978-9-81-429937-4.
  3. 1 2 Fibiger, J. (1919). "On Spiroptera carcinomata and their relation to true malignant tumors; with some remarks on cancer age". The Journal of Cancer Research. 4 (4): 367–387. doi:10.1158/jcr.1919.367 (inactive 2024-09-12).{{cite journal}}: CS1 maint: DOI inactive as of September 2024 (link)
  4. 1 2 3 4 Lalchhandama, K. (2017). "The making of oncology: The tales of false carcinogenic worms" (PDF). Science Vision. 17 (1): 33–52. doi:10.33493/scivis.17.01.06. Archived from the original (PDF) on 2017-04-24. Retrieved 2017-04-23.
  5. ↑ Fibiger, J.; Ditlevsen, H. (1914). "Contributions to the biology and morphology of Spiroptera (Gongylonema) neoplastica n. sp". Mindeskrift i anledning af hundredaaret for Japetus Steenstrups fødsel. 25 (1–28).
  6. ↑ Ditlevsen, H. (1918). "Über Gongylonema neoplasticum (Spiroptera (Gongylonema) neoplastica Fibiger et Ditlevsen)". Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abteilung Originale. 81: 565–576.
  7. ↑ Kruidenier, F. J.; Peebles, C. R. (1958). "Gongylonema of Rodents: G. neoplasticum (Redefinition); G. dipodomysis n. sp.; and G. peromysci n. sp". Transactions of the American Microscopical Society. 77 (3): 307–315. doi:10.2307/3223695. JSTOR   3223695.
  8. ↑ Yokogawa, Sadamu (1925). "On a new species of nematode, Gongylonema orientale, found in Formosa". The Journal of Parasitology. 11 (4): 195–200. doi:10.2307/3270828. JSTOR   3270828.
  9. ↑ Ransom, B.H.; Hall, M.C. (1915). "The life-history of Gongylonema scutatum". Journal of Parasitology. 2 (2): 80–86. doi:10.2307/3271023. JSTOR   3271023.
  10. ↑ Yamagiwa, K.; Ichikawa, K. (1918). "Experimental study of the pathogenesis of carcinoma". The Journal of Cancer Research. 3 (1): 1–29. doi:10.1158/jcr.1918.1 (inactive 2024-09-12).{{cite journal}}: CS1 maint: DOI inactive as of September 2024 (link)
  11. ↑ Narat, J. K. (1925). "Experimental production of malignant growths by simple chemicals". The Journal of Cancer Research. 9 (1): 135–147. doi: 10.1158/jcr.1925.135 .
  12. ↑ Kuper, H.; Adami, H.-O.; Trichopoulos, D. (2000). "Infections as a major preventable cause of human cancer". Journal of Internal Medicine. 248 (3): 171–183. doi: 10.1046/j.1365-2796.2000.00742.x . PMID   10971784.
  13. ↑ "Johannes Fibiger - Nominations". www.nobelprize.org. Nobel Media AB. Retrieved 23 April 2017.
  14. ↑ Stolt, CM; Klein, G; Jansson, AT (2004). "An analysis of a wrong Nobel Prize-Johannes Fibiger, 1926: a study in the Nobel archives". Advances in Cancer Research. 92: 1–12. doi:10.1016/S0065-230X(04)92001-5. ISBN   9780120066926. PMID   15530554.
  15. 1 2 Stolt, C.-M.; Klein, G.; Jansson, A.T.R. (2004). "An Analysis of a Wrong Nobel Prize—Johannes Fibiger, 1926: A Study in the Nobel Archives". In Woude, G.F.V.; Klein, G. (eds.). Advances in cancer research . California (US): Elsevier Academic Press. pp.  1–13. ISBN   9780080522296.
  16. ↑ "The Nobel Prize in Physiology or Medicine 1926". www.nobelprize.org. Nobel Media AB. Retrieved 23 April 2017.
  17. ↑ Bullock, F. D.; Rohdenburg, G. L. (1918). "Experimental "carcinomata" of animals and their relation to true malignant tumors". The Journal of Cancer Research. 3 (3): 227–273. doi:10.1158/jcr.1918.227 (inactive 2024-09-12).{{cite journal}}: CS1 maint: DOI inactive as of September 2024 (link)
  18. ↑ Passey, R. D.; Leese, A.; Knox, J. C. (1935). "Spiroptera cancer and diet deficiency". Journal of Pathology and Bacteriology. 40 (1): 198–199.
  19. ↑ Tyson, M. D.; Smith, A. H. (1929). "Tissue changes associated with Vitamin A deficiency in the rat". The American Journal of Pathology. 5 (1): 57–70. PMC   2007212 . PMID   19969830.
  20. ↑ Sugiura, K.; Benedict, S. R. (1930). "A critical study of vitamin A and carcinogenesis". The Journal of Cancer Research. 14 (2): 306–310. doi:10.1158/jcr.1930.306 (inactive 2024-09-12).{{cite journal}}: CS1 maint: DOI inactive as of September 2024 (link)
  21. ↑ Sugiura, K.; Benedict, S. R. (1930). "The influence of high fat diets on the growth of carcinoma and sarcoma in rats". The Journal of Cancer Research. 14 (2): 311–318. doi:10.1158/jcr.1930.311 (inactive 2024-09-12).{{cite journal}}: CS1 maint: DOI inactive as of September 2024 (link)
  22. ↑ Cramer, W. (1937). "Papillomatosis in the forestomach of the rat and its bearing on the work of Fibiger". The American Journal of Cancer. 31 (4): 537–555. doi: 10.1158/ajc.1937.537 .
  23. ↑ Hitchcock, Claude R.; Bell, E. T. (1952). "Studies on the nematode parasite, Gongylonema Neoplasticum (Spiroptera Neoplasticum), and avitaminosis a in the forestomach of rats: Comparison with Fibiger's results". Journal of the National Cancer Institute. 12 (6): 1345–1387. doi:10.1093/jnci/12.6.1345. PMID   14939031.
  24. ↑ Oettlé, A. G. (1962). "A historical review of past histopathological material at the South African Institute for Medical Research between 1911 and 1927". South African Medical Journal. 36 (31): 628–631.
  25. ↑ Clemmesen, J (1978). "Johannes Fibiger. Gongylonema and vitamin A in carcinogenesis". Acta Pathologica et Microbiologica Scandinavica. 270 (Suppl): 1–13. PMID   362817.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.